We are live on ! Find out more
PACB icon

Pacific Biosciences
PACB

151 hedge funds and large institutions have $375M invested in Pacific Biosciences in 2020 Q2 according to their latest regulatory filings, with 34 funds opening new positions, 47 increasing their positions, 38 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

127% more first-time investments, than exits

New positions opened: 34 | Existing positions closed: 15

116% more call options, than puts

Call options by funds: $1.18M | Put options by funds: $545K

24% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 38

14% more funds holding

Funds holding: 132 → 151 (+19)

4% more capital invested

Capital invested by funds: $361M → $375M (+$14.2M)

6.38% less ownership

Funds ownership: 76.89% → 70.5% (-6.4%)

50% less funds holding in top 10

Funds holding in top 10: 2 → 1 (-1)

Holders
151
Holders Change
+19
Holders Change %
+14.39%
% of All Funds
3.1%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
34
Increased
47
Reduced
38
Closed
15
Calls
$1.18M
Puts
$545K
Net Calls
+$631K
Net Calls Change
+$791K

Top Buyers

1
AIM
ARK Investment Management
Florida
+$13.7M
2
Morgan Stanley
Morgan Stanley
New York
+$3.94M
3
BG
Bellevue Group
Switzerland
+$3.35M
4
State Street
State Street
Massachusetts
+$2.25M
5
Ameriprise
Ameriprise
Minnesota
+$2.14M

Top Sellers

1
WMSA
Weiss Multi-Strategy Advisers
New York
-$13.7M
2
ACH
ArrowMark Colorado Holdings
Colorado
-$8.62M
3
CCM
Camber Capital Management
Massachusetts
-$7.65M
4
Goldman Sachs
Goldman Sachs
New York
-$5.78M
5
KLCMU
Kite Lake Capital Management (UK)
United Kingdom
-$5.08M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$46M +$1.73M +508,752 +4%
BG
2
Bellevue Group
Switzerland
$28.9M +$3.35M +984,950 +13%
AIM
3
ARK Investment Management
Florida
$28.4M +$13.7M +4,038,433 +96%
Vanguard Group
4
Vanguard Group
Pennsylvania
$27.5M +$1.74M +511,325 +7%
Capital International Investors
5
Capital International Investors
California
$23.4M – – –
Capital World Investors
6
Capital World Investors
California
$18.8M – – –
WIC
7
Water Island Capital
New York
$18.7M -$118K -34,800 -0.6%
State Street
8
State Street
Massachusetts
$14.6M +$2.25M +659,610 +18%
KLCMU
9
Kite Lake Capital Management (UK)
United Kingdom
$13.8M -$5.08M -1,492,900 -27%
PC
10
Polar Capital
United Kingdom
$12.9M +$596K +175,024 +5%
GCM
11
Glenview Capital Management
New York
$10.9M -$257K -75,345 -2%
FCM
12
Farallon Capital Management
California
$10.3M – – –
Blackstone Inc
13
Blackstone Inc
New York
$8.32M – – –
GF
14
Gabelli Funds
New York
$8.08M -$91.9K -27,000 -1%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$7.66M +$239K +70,238 +3%
Millennium Management
16
Millennium Management
New York
$7.02M -$1.08M -315,834 -13%
Northern Trust
17
Northern Trust
Illinois
$6.59M +$369K +108,371 +6%
PAMU
18
Pictet Asset Management (UK)
United Kingdom
$6.07M – – –
OIM
19
Oracle Investment Management
Connecticut
$4.55M +$340K +100,000 +8%
Morgan Stanley
20
Morgan Stanley
New York
$4.42M +$3.94M +1,157,197 +930%
Ameriprise
21
Ameriprise
Minnesota
$3.7M +$2.14M +629,869 +142%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$3.52M -$162K -47,611 -4%
MF
23
Magnetar Financial
Illinois
$3.49M -$3.35M -984,309 -49%
Assenagon Asset Management
24
Assenagon Asset Management
Luxembourg
$3.41M -$1.85M -542,166 -35%
Charles Schwab
25
Charles Schwab
California
$3.27M +$223K +65,560 +7%
1
2 3 4 5

PACB Hedge Fund Activity: Q2 2020 in Review

151 of the 4,877 institutional investors tracked by Wall St. Rank reported a position in Pacific Biosciences (PACB) for Q2 2020, worth a combined $375M — up 3.9% from $361M a quarter earlier.

Buyers outnumbered sellers: 34 funds opened new PACB positions and 15 closed out — a net gain of 19 holders — while 47 added to existing stakes and 38 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $13.7M. The largest seller was Weiss Multi-Strategy Advisers, cutting an estimated $13.7M.

  • 151 institutional investors held Pacific Biosciences (PACB) as of Q2 2020, up from 132 in Q1 2020.
  • Funds reported $375M of Pacific Biosciences stock for Q2 2020, up 3.9% quarter-over-quarter.
  • 34 funds opened new Pacific Biosciences positions in Q2 2020 and 15 closed out, a net change of +19 holders.
  • The largest Pacific Biosciences buyer in Q2 2020 was ARK Investment Management, an estimated $13.7M added.
  • The largest Pacific Biosciences seller in Q2 2020 was Weiss Multi-Strategy Advisers, an estimated $13.7M sold.

Based on aggregated 13F filings for Q2 2020.